IL10 and metabolic syndrome: The rs615563, on the other hand, was associated with a lower risk of having central obesity, metabolic syndrome, hyperinsulinemia, insulin resistance, insulin resistance of adipose tissue, low risk of increased alkaline phosphatase >p75, and low risk of having decreased interleukin 10 <p25.